Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

Press releases published on October 13, 2026

Oct. 13, 2026

Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

Indeterminate GlobeNewswire

Oct. 13, 2026

Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update

Indeterminate GlobeNewswire

Oct. 13, 2026

Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis

Indeterminate GlobeNewswire

Oct. 13, 2026

Vetty Announces New Leadership Team to Accelerate AI-Driven Transformation of Hiring

Indeterminate GlobeNewswire

Oct. 13, 2026

New Enterprise Adapter Offers a Supported PowerPlan Integration Between PowerPlan and Oracle® Fusion Cloud ERP

Indeterminate GlobeNewswire

Oct. 13, 2026

Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity

Indeterminate GlobeNewswire

Oct. 13, 2026

Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 13, 2026

Foresight Signed a Non-Binding Term Sheet to Acquire 50.01% in a 270MW Capacity European Data Center Development Company

Indeterminate GlobeNewswire

Oct. 13, 2026

BioNTech veröffentlicht Update zur klinischen Phase-2/3-Studie des mRNA-Krebsimmuntherapiekandidaten BNT113 bei HPV16-positivem metastasiertem Kopf- und Halskrebs

Indeterminate GlobeNewswire

Oct. 13, 2026

BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer 

Indeterminate GlobeNewswire

Oct. 13, 2026

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2026

Indeterminate GlobeNewswire

Oct. 13, 2026

Symbotic Announces Acquisition of cellumation, Advancing Next-Generation Sortation Technology for the Global Supply Chain

Indeterminate GlobeNewswire

Oct. 13, 2026

Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026

Indeterminate GlobeNewswire

Oct. 13, 2026

Istios Health Expands Pittsburgh Center of Excellence with Pittsburgh Gastroenterology Associates Partnership

Indeterminate GlobeNewswire

Oct. 13, 2026

Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045

Indeterminate GlobeNewswire

Oct. 13, 2026

Jabra WorkLife Report Unveils a Productivity Paradox: AI is Giving Workers Time Back, But They're Not Working Any Less

Indeterminate GlobeNewswire

Oct. 13, 2026

Travelan® Phase 2 Study Results Published

Indeterminate GlobeNewswire

Oct. 13, 2026

Healthcare Sees No Relief from Cyberattacks Disrupting Patient Care

Indeterminate GlobeNewswire

Oct. 13, 2026

Holafly bringt Ultra auf den Markt und erweitert sein globales eSIM-Abonnement um Gesundheits- und Wellnessangebote

Indeterminate GlobeNewswire

Oct. 13, 2026

Holafly lanza Ultra, incorporando servicios de salud y bienestar a su suscripción global de eSIM

Indeterminate GlobeNewswire